Companies Now Delivering Regulatory Services to the Pharmaceutical IndustryWestminster, CO — April 30, 2020 — Flagship Biosciences, providers of expert tissue data insights, today announced an alliance with Corritori Consulting Inc., a biopharmaceutical and regulatory...
News
News and Insights from Our Multidisciplinary Team of Experts
Flagship Spotlight: Sara Wells
Sara Wells is a histotechnician at Flagship Biosciences. She recently shared some background for a spotlight article, as well as an update on working during the COVID-19 outbreak. Sara received her BS in Biotechnology from Kent State University. She says she has...
Flagship Biosciences Hires New Vice President of Clinical Diagnostics
Westminster, CO — March 31, 2020 — Flagship Biosciences, providers of expert tissue data insights, today announced that Geoff Metcalf, MBA, PMP, will join its executive team as Vice President Clinical Diagnostics. Geoff brings 25 years of experience in developing and...
Flagship Spotlight: Elliott Ergon
Elliott Ergon a Research and Development Process Engineer at Flagship Biosciences. He studied chemical and biological engineering at the University of Colorado – Boulder and received his BS. Elliott shared what led him to his work in science. “Growing up I always had...
Flagship Spotlight: Michael Argyres, MD
Michael Argyres, MD, is Flagship’s Director of Pathology, diagnostic biomarkers. Mike received his BA at UC Berkeley in molecular biology, his MD at the Medical College of Wisconsin, did his pathology residency at the University of Colorado, a surgical pathology...
Flagship Spotlight: Chuck Caldwell, PhD
Flagship scientist Chuck Caldwell received his PhD in Biological Engineering at the University of Missouri and BS, Biological Engineering, also at the University of Missouri, and did postdoctoral studies at the University of Colorado. He recently shared some of his...
Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.
Recent Posts
PUBLICATIONS/POSTERS
Combined Immunohistochemistry And NGS-Based Patient Profiling For Predicting Anti-PD-1/PD-L1 Therapy Response
Key Takeaways Successful pathology AI does not replace, but assist pathologists in high-complexity tissue analysis Transparency and control is retained in a pathologist-centric AI-based system Pathology AI enables cost effective healthcare by testing for multiple...
Building Predictive Models Of Clinical Outcomes In Immune Oncology Using Computational Tissue Analysis Scorecards
Key takeaways Building Predictive Models of Clinical Outcomes in Immune Oncology Using Computational Tissue Analysis Scorecards The spatial location of PD-L1 expression can identify patients who will likely respond to anti-PD-1/PD-L1 therapy Flagship’s unique spatial...
Pathologists Versus AI
Artificial intelligence (AI) systems for pathology may appear to compete with manual pathology, as they enable the assessment of thousands of cells and application of complex scoring schemes beyond the capacity of a human pathologist. However, this technology...
EVENTS
SITC 2022
Visit Flagship at SITC | Booth #818.November 8-12, 2022.Stop by our booth to meet our new CSO Tom Turi, Ph.D., and talk with us about how we can partner with you for end-to-end biomarker support. Come learn about our new services, and pick up a map of our favorite...
World CB & CDx 2022
Visit Flagship at World CB & CDx | Booth #4. Boston, MA | September 26-29, 2022. Stop by our booth to talk with us about how we can partner with you for end-to-end biomarker support and see our latest data. Assay development and validation Clinical trial support...
AACR 2022
Visit Flagship at AACR | Booth #1554. April 8-13, 2022. Stop by our booth to talk with us about how we can partner with you for end-to-end biomarker support, see our latest data from this year’s featured posters, and pick up a map of our favorite NOLA eateries. Assay...